脂联素、超敏C反应蛋白水平变化对脑梗死治疗效果的判断

目的观察脂联素（APN）和超敏C反应蛋白（HsCRP）水平的变化，对急性脑梗死患者治疗的影响。方法选择64例急性脑梗死患者，随机分为治疗组32例、对照组32例，治疗组采用疏血通联合阿魏酸钠治疗，对照组采用胞二磷胆碱治疗。对脑梗死患者分别在治疗前后进行脂联素（APN）和超敏C反应蛋白（HsCRP）水平的检测。结果两组患者治疗前后脂联素（APN）和超敏C反应蛋白（HsCRP）水平差异有统计学意义（P〈0．01，P〈0．05），且两组治疗后差异均有统计学意义（P〈0．05）。结论脂联素和超敏C反应蛋白能反映急性脑梗死病情变化。

Effects of shuxuetong plus Sodium ferulate on the APN and HsCRP Levels of Patients With Cerebral Infarction

Objective To investigate the changes of APN and HsCRP levels in patients with cerebral infarction and to observe whether treated with shuxuetong plus sodium ferulate improves the APN and HsCRP levels of patients with cerebral infarction.Methods All patients were randomly divided into treated group and control group.Patients in treated group were treated with shuxuetong and sodium ferulate.Patients in control group were treated with Citicoline.Plasma APN and HsCRP levels were measured in all patients before and after treatent.Results The levels of plasma APN and HsCRP in the two groups before and after treatment were significantly different respectively(P＜0.01,P＜0.05).After treated,the levels of plasma APN and HsCRP in treated group wee better than those in control group(P＜0.05).Conclusion Shuxuetong plus sodium ferulate can effectively improve plasma APN and HsCRP levels of cerebral infarction.